Colt CZ Group (CZG) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
18 Sep, 2025Executive summary
Revenues for 6M 2025 reached CZK 11,015m, up 13.7% year-over-year, driven by ammunition segment growth and full consolidation of Sellier & Bellot.
Adjusted EBITDA grew 19.2% to CZK 2,361m, while adjusted net profit slightly declined by 1.3% to CZK 1,002m.
Ammunition segment showed strong profitability and growth in Europe, offsetting US market softness and a 26% decline in firearms segment revenues.
Strategic acquisitions included Valley Steel Stamp (VSS) and a 51% stake in Synthesia Nitrocellulose (SNC), enhancing vertical integration and supply chain control.
Major contracts signed in Europe and Canada, reinforcing position in NATO markets.
Financial highlights
Adjusted EPS for 6M 2025 was CZK 17.8, up 28.4% year-over-year; adjusted net earnings per share was CZK 17.7 (down from CZK 24.8 year-over-year).
Adjusted net profit without S&B PPA amortization effect increased 12.8% to CZK 1,305m.
EBITDA increased 61.6% year-over-year to CZK 2,358.3m; adjusted EBITDA margin was 21.4%.
Net financial debt at CZK 12,616m, with a net leverage ratio of 2.24x as of 6M 2025.
Capital expenditures reached CZK 362m, mainly in the Czech Republic.
Outlook and guidance
FY 2025 revenue guidance is CZK 25bn ±10%, with EBITDA guidance at CZK 5.5bn ±10%.
Capital expenditures for 2025 expected at CZK 1.1–1.3bn (approx. 5% of revenues).
Net interest costs for 2025 are guided at CZK 599m.
U.S. tariffs on European imports (15%) expected to have low single-digit impact on EBITDA; no revision to full-year guidance.
Guidance does not include the impact of the SNC acquisition.
Latest events from Colt CZ Group
- Net profit surged as ammunition growth offset U.S. firearms weakness; 2026 set for major gains.CZG
Q4 202525 Mar 2026 - Revenue and net profit surged, with acquisitions and bond issuance fueling future growth.CZG
Q3 202520 Nov 2025 - Revenue up 51%, but net profit down on acquisition costs; guidance and leverage targets met.CZG
Q3 202413 Jun 2025 - Record H1 2024 revenue and EBITDA growth driven by Sellier & Bellot acquisition and US recovery.CZG
Q2 202413 Jun 2025 - Q1 2025 revenue up 50% and profit up 73%, with U.S. tariffs posing EBITDA risk.CZG
Q1 20259 Jun 2025 - 2024 revenue up 50.6% to CZK 22.4bn, with 2025 growth and profit distribution split expected.CZG
Q4 20249 Jun 2025